Exclusive

Publication

Byline

IASO Bio receives FDA IND clearance for CD20-targeted in vivo CAR-T therapy

Singapore, Sept. 18 -- IASO Biotechnology has received US Food and Drug Administration clearance for the Investigational New Drug application of IASO208, its CD20-targeted in vivo CAR-T therapy. IASO... Read More


Gujarat Themis Biosyn completes acquisition of Japan-based MicroBiopharm to boost fermentation capabilities

Singapore, Sept. 18 -- India-based Gujarat Themis Biosyn Limited (GTBL) has announced the completion of the acquisition of 100% equity shareholding in MicroBiopharm Japan (MBJ), through Themis Biosyn ... Read More


Avantor expands RIM single-use portfolio of bioprocessing solutions across APAC

Singapore, Sept. 17 -- Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, is expanding availabilit... Read More


Swiss firm Tenthpin expands footprint in India with AI, IoMT-based Centre for Life Sciences Innovation Hub in Bengaluru

Singapore, Sept. 17 -- Switzerland based Tenthpin Management Consultants, a global leader in management and technology consulting for Life Sciences companies, has announced the launch of Innovation Hu... Read More


China's WuXi XDC out-licenses Payload-Linker Technology Platform to Ona Therapeutics for ADC research

Singapore, Sept. 17 -- WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialising in antibody-drug conjugates (ADCs) and other bioconjug... Read More


Shilpa Biologicals and SPIMACO Bio sign strategic license agreement for PD-1 Biosimilar for MENA market

Singapore, Sept. 16 -- Shilpa Biologicals, an India-based integrated biologics development and manufacturing organisation, has announced an exclusive Middle East and North Africa (MENA) strategic lice... Read More


GSK buys T cell-engager for multiple myeloma treatment from China's Chimagen Biosciences for $750 M

Singapore, Sept. 16 -- GSK plc has entered an agreement to acquire a potential best-in-class trispecific T cell-engager (TCE) from Chimagen Biosciences, a China-based biotechnology company. GSK plans ... Read More


FedEx mobilises over 590 volunteers across Asia Pacific for inaugural Day of Service

Singapore, Sept. 16 -- Federal Express Corporation has completed its inaugural Frederick W. Smith Day of Service across Asia Pacific, bringing together more than 590 volunteers in community and enviro... Read More


Korea establishes public-private pharmaceutical industry innovation council

Singapore, Sept. 16 -- The Ministry of Health and Welfare (MOHW), South Korea government, has announced the launch of the Public-Private Pharmaceutical Industry Innovation Council and held its inaugur... Read More


Israel's P-Cure signs binding agreement with ARISTION to build India's first Compact Proton Therapy network

Singapore, Sept. 16 -- Israeli medical technology company P-Cure and Indian healthcare company ARISTION Proton Centre have announced the signing of a binding agreement to deploy P-Cure's compact, sync... Read More